Loading...
Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
The Wuhan outbreak of novel Corona virus infection has been the global focus since December 2019. This infection has become a global pandemic. It is highly important to understand the virology of the pathogen and to explore the therapeutic options for management of this pandemic. Drug repurposing st...
Na minha lista:
| Udgivet i: | Int J Antimicrob Agents |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7128600/ https://ncbi.nlm.nih.gov/pubmed/32259575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.105967 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|